Landscape of KRAS G12C , Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS -Mutated Cancers.
Mohamed E SalemSherif M El-RefaiWei ShaAlberto PucciniAxel GrotheyThomas J GeorgeJimmy J HwangBert O'NeilAlexander S BarrettKunal C KadakiaLaura W MusselwhiteDerek RaghavanEric Van CutsemJosep TaberneroJeanne TiePublished in: JCO precision oncology (2022)
tumors exhibited a distinct comutation profile and were associated with tumor mutational burden-high status.